GlaxoSmithKline Pharmaceuticals Limited — Dividend/Bonus, 29-10-2024: Dividend

GlaxoSmithKline Pharmaceuticals Limited published its unaudited financial results for the second quarter and half-year ended September 30, 2024. The company reported a revenue of ₹100,005 lakhs and a profit of ₹24,869 lakhs for the quarter. The Board declared a special interim dividend of ₹12 per share. Overall, the financial performance shows positive growth compared to previous periods, along with improved cash flow management.